Register

I agree with the Privacy Policy

Los Angeles Times

Medical giant Medtronic to buy rival Covidien for $42.9 billion

June 15, 2014

Because both companies already are giants in the medical-devices market, the merger should allow for more robust research and development and more comprehensive health-monitoring capabilities, said Harry Wang, a health industry analyst at product research firm Parks Associates.

The medical devices industry has been plagued by slow innovation, but the merger should advance the market, Wang said.

“By buying up this company and consolidating R&D spending, they have a better chance of getting their products to market,” he said. “Over the long term, if R&D is spent wisely and effectively, you will see more cost-effective products for consumers.”

From the article, "Medical giant Medtronic to buy rival Covidien for $42.9 billion" by Javier Panzar.

Previously In The News

After initial flop, Google will try again to launch Android TV

Barbara Kraus, market research director at Parks Associates, said about a third of U.S. households with broadband Internet have smart TVs, a percentage expected to double by 2018. But the top t...

Why not pull the plug on cable

Not subscribing to a cable, satellite or telco provider does have some downsides. It means saying goodbye to ESPN and other popular networks that air things as they happen, although some news servi...

Now showing in rich people's homes: first-run movies

"There are thousands of people out there, if not tens of thousands of people, that could buy this product," Pang said. "We found the secret sauce to make billionaires act like little giddy schoolch...

Wearable devices are unlikely to be big sellers, analysts say

Still, amid signs of a slowdown in smartphone sales and pressure to come up with the next big thing, tech companies are jumping on the wearable tech trend. Many analysts expect Apple, Google and Sa...

1
2
3
4
5
6
7
8
9
10
›